Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ectonucleotide pyrophosphatase/phosphodiesterase 2 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0759 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0023 | 0.0249 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0249 | 1 |
Trypanosoma cruzi | DNA/RNA non-specific endonuclease protein-like, putative | 0.0024 | 0.0306 | 0.5 |
Echinococcus granulosus | ectonucleotide pyrophosphatase:phosphodiesterase | 0.004 | 0.0999 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0087 | 0.301 | 1 |
Schistosoma mansoni | ectonucleotide pyrophosphatase/phosphodiesterase | 0.004 | 0.0999 | 0.2563 |
Trypanosoma brucei | endonuclease G, putative | 0.0024 | 0.0306 | 0.5 |
Schistosoma mansoni | ectonucleotide pyrophosphatase/phosphodiesterase | 0.004 | 0.0999 | 0.2563 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0017 | 0 | 0.5 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0023 | 0.0249 | 1 |
Brugia malayi | Thrombospondin type 1 domain containing protein | 0.0087 | 0.301 | 0.2832 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0999 | 0.0999 |
Loa Loa (eye worm) | thrombospondin type 1 domain-containing protein | 0.0087 | 0.301 | 0.301 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0249 | 0.0249 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0023 | 0.0249 | 0.5 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0023 | 0.0249 | 1 |
Trypanosoma cruzi | endonuclease G, putative | 0.0024 | 0.0306 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0759 | 1 |
Loa Loa (eye worm) | O-glycosyl hydrolase family 30 protein | 0.025 | 1 | 1 |
Brugia malayi | endonuclease G, mitochondrial precursor | 0.0024 | 0.0306 | 0.0059 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.025 | 1 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0035 | 0.0759 | 0.6536 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0035 | 0.0759 | 0.1675 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0023 | 0.0249 | 1 |
Trypanosoma brucei | endonuclease G, putative | 0.0024 | 0.0306 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0759 | 1 |
Echinococcus multilocularis | ectonucleotide pyrophosphatase:phosphodiesterase | 0.004 | 0.0999 | 1 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0017 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0999 | 0.0999 |
Echinococcus multilocularis | ectonucleotide pyrophosphatase:phosphodiesterase | 0.004 | 0.0999 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0249 | 0.0249 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0249 | 0.0249 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0726 | 0.0726 |
Onchocerca volvulus | 0.0087 | 0.301 | 0.4557 | |
Echinococcus multilocularis | ectonucleotide pyrophosphatase:phosphodiesterase | 0.004 | 0.0999 | 1 |
Echinococcus granulosus | ectonucleotide | 0.0034 | 0.0726 | 0.6061 |
Echinococcus multilocularis | ectonucleotide pyrophosphatase:phosphodiesterase | 0.004 | 0.0999 | 1 |
Echinococcus granulosus | ectonucleotide pyrophosphatase:phosphodiesterase | 0.004 | 0.0999 | 1 |
Onchocerca volvulus | Glucosylceramidase homolog | 0.0164 | 0.6308 | 1 |
Echinococcus granulosus | ectonucleotide pyrophosphatase:phosphodiesterase | 0.004 | 0.0999 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0249 | 1 |
Echinococcus multilocularis | ectonucleotide pyrophosphatase:phosphodiesterase | 0.004 | 0.0999 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.0759 | 0.1675 |
Echinococcus granulosus | ectonucleotide pyrophosphatase:phosphodiesterase | 0.0034 | 0.0726 | 0.6061 |
Brugia malayi | Type I phosphodiesterase / nucleotide pyrophosphatase family protein | 0.004 | 0.0999 | 0.0769 |
Leishmania major | endonuclease G, putative | 0.0024 | 0.0306 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0249 | 1 |
Echinococcus multilocularis | ectonucleotide | 0.0034 | 0.0726 | 0.6061 |
Trypanosoma cruzi | DNA/RNA non-specific endonuclease protein-like, putative | 0.0024 | 0.0306 | 0.5 |
Echinococcus granulosus | ectonucleotide pyrophosphatase:phosphodiesterase | 0.004 | 0.0999 | 1 |
Onchocerca volvulus | 0.004 | 0.0999 | 0.1238 | |
Trichomonas vaginalis | glucosylceramidase, putative | 0.025 | 1 | 1 |
Leishmania major | DNA/RNA non-specific endonuclease-like protein | 0.0024 | 0.0306 | 1 |
Trypanosoma brucei | endonuclease G, putative | 0.0024 | 0.0306 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0999 | 0.0999 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0173 | 0.6687 | 0.1027 |
Onchocerca volvulus | 0.004 | 0.0999 | 0.1238 | |
Echinococcus granulosus | ectonucleotide pyrophosphatase:phosphodiesterase | 0.004 | 0.0999 | 1 |
Trypanosoma cruzi | endonuclease G, putative | 0.0024 | 0.0306 | 0.5 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0173 | 0.6687 | 0.1027 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.025 | 1 | 1 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0023 | 0.0249 | 0.5 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.025 | 1 | 1 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0023 | 0.0249 | 1 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0023 | 0.0249 | 1 |
Toxoplasma gondii | DNA/RNA non-specific endonuclease | 0.0024 | 0.0306 | 0.5 |
Schistosoma mansoni | ectonucleotide pyrophosphatase/phosphodiesterase | 0.004 | 0.0999 | 0.2563 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.025 | 1 | 1 |
Schistosoma mansoni | ectonucleotide pyrophosphatase/phosphodiesterase | 0.004 | 0.0999 | 0.2563 |
Echinococcus multilocularis | ectonucleotide pyrophosphatase:phosphodiesterase | 0.004 | 0.0999 | 1 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0017 | 0 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0035 | 0.0759 | 0.6536 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0759 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.025 | 1 | 1 |
Echinococcus multilocularis | ectonucleotide pyrophosphatase:phosphodiesterase | 0.0034 | 0.0726 | 0.6061 |
Brugia malayi | hypothetical protein | 0.0035 | 0.0759 | 0.0523 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0023 | 0.0249 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 25 % | Reduction of autotaxin and lysophosphatidyl choline-induced cell migration in human A2058 cells at 30 uM after 4 to 48 hrs by monolayer scratch assay | ChEMBL. | 23816044 |
IC50 (binding) | = 1 uM | Inhibition of C-terminal FLAG-tagged human recombinant autotaxin using synthetic substrate FS-3 measured every 2 mins by FRET assay | ChEMBL. | 23816044 |
Inhibition (binding) | = 10.6 % | Inhibition of C-terminal FLAG-tagged human recombinant autotaxin using paranitrophenyl thymidine monophosphate as substrate at 10 uM measured every 2 mins by FRET assay relative to control | ChEMBL. | 23816044 |
Inhibition (binding) | = 64.7 % | Inhibition of C-terminal FLAG-tagged human recombinant autotaxin using synthetic substrate FS-3 at 10 uM measured every 2 mins by FRET assay relative to control | ChEMBL. | 23816044 |
Ki (binding) | = 1.6 uM | Competitive inhibition of C-terminal FLAG-tagged human recombinant autotaxin using synthetic substrate FS-3 by Michaelis-Menten equation analysis | ChEMBL. | 23816044 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.